SlideShare a Scribd company logo
Gestational Diabetes
        (GD)

            Presented by
   DR . HINA KHUDA-I-DAD
     Working under supervision of
  PROF. DR .TASNEEM ASHRAF
  HEAD OF DEPARTMENT GYNAE UNIT IV
INTRODUCTION

Gestational diabetes is Any degree of
Glucose intolerance with onset or first
recognition during pregnancy.
It affects 3-5% of all pregnancies.
PRENATAL MANAGEMENT


 1- Screening and diagnosis
 2-PATIENT’S EDUCATION
 3-GLYCEMIC TARGETS
 4-DIET AND EXERCISE
 5-INSULIN AND ORAL HYPO-
    GLYCEMIC DRUGS
 6-MONITORING FETAL
 GROWTH
WHO SHOULD BE SCREENED
AND WHY

Risk stratification

 Low risk: no screening


 Average risk: at 24-28 weeks


 High risk: as soon as possible
LOW RISK

 Age <25 years
 Weight normal before pregnancy
 Member of an ethnic group with a low
 prevalence of GDM
 No known diabetes in first-degree relatives
 No history of abnormal glucose tolerance
 No history of poor obstetric outcome
In the presence of all these factors no screening
   is recommended
INTERMEDIATE RISK

 Must exhibit one risk factor of GDM.
Caution




High risk of gestational diabetes
 Marked obesity BMI >30.
 Previous history of gestational diabetes mellitus.
 Strong family history of diabetes .
 Native Americans, Asians, Hispanics, African AND
  arabic specially of mid-eastern origin.
 Previous macrosomic babies, unexplained stillbirths.
     women with risk factors should be screened as
  soon as possible
Oral glucose tolerance
                 test
Prerequisites:
   Normal diet for 3 days before the test.
   At least 10 hours fast ,in morning at rest.
Give 100 gm of glucose in 250 ml water
Criteria for glucose tolerance test:

    fasting             5.3 mmol/L
    1 hour              10 mmol/L
    2 hours       8.6 mmol/L
    3 hours       7.8 mmol/L
         If any 2 or more of these values are elevated, the patient is DIAGNOSED to
    have GDM.ADA CRITERIA
Patient education
cornerstone in GDM management
 Inform mother about maternal and fetal
    complications
   Diet therapy
   Teach mother about self monitored blood
    glucose measurement and glycemic targets
   Fetal monitoring: ultrasound
   Planning on delivery
Potential Risks of
Untreated GDM
       IN CHILD
1,Growth abnormalities
   -Macrosomia
2,Chemical imbalance
    -Hypoglycemia
    -Jaundice
    -Hypocalcemia
Prone for diabetes in future
Potential Risks of Untreated
GDM in mother
 PIH and Pre-eclampsia: affects 10-25% of all pregnant
  women with GDM
 Infections: high incidence of chorioamnionitis and
  postpartum endometritis
 Postpartum bleeding: caused by exaggerated uterine
  distension
 Ceasarian section due to fetal macrosmia and cephalo-
  pelvic disproportion
 Weight gain
 Third trimester fetal deaths
 Long term risk of type-2 diabetes mellitus
GLYCEMIC TARGET



1.Fasting              <5.9mmol/L
2.1 hr post prandial   <7.8 mmol/L
Self monitored blood glucose
(SBMG)

4 times/day minimum, fasting and 1 or 2 hours
after meals

Maintain log book
DIET
Diet


Proteins        not more than 1g/kg
Fats            < 35% of energy intake
Cho             <55% of energy intake
Salt             <6g/day
           In 3 meals and 3 snacks
Exercise


 Means regular, moderate
physical activity like

1. Walking for 14-30 minutes
2. Prenatal Aerobic classes
3. Swimming
INSULIN
THERAPY



 If persistent hyperglycemia after one week of
  diet control proceed to insulin
INSULIN IN GDM

 Insulin used if fasting blood glucose >105
  mg/dl or 2 hr postprandial blood glucose >120
  mg / dl on a diet
 Use intermittent bolus regime of Short
  acting insulins to cover each meal.
 Insulin requirements increase by 50% from
  20-24 weeks to 30-32 weeks, after which
  insulin needs often stabilize.
ORAL HYPOGLYCEMIC
AGENTS
 Glyburide is a clinically effective alternative to
  insulin in GDM (Langer et al. 2000)
 Metformin may be effective in GDM (Ratner
  et al., 2008; Coustan, 2007
HYPOGLYCEMIA

 During treatment with insulin patient can
  have low blood sugar <60mg/dl
 Why does low blood sugar occur?
1. Too much exercise
2. Skipping meals or snacks
3. Delaying meals or snacks
4. Not eating enough
5. Too much insulin
SYMPTOMS OF
HYPOGLYCEMIA
 Very hungry
 Very tired
 Shaky or trembling
 Sweating or clamminess
 Nervous
 Confused
 Like going to pass out or faint
 Blurred vision
Hypoglycemia
Prevention Strategies
   Consistent monitoring
Fetal monitoring

  (1) Ultrasound :NICE guideline is to assess
fetal growth on 4 weekly basis from 28-36wks
 Fetal growth ,Amniotic fluid volume at
28,32,36 wks polyhydramnios
(2) cardiotocography (C.T.G). after 32 wks
(3) Doppler.
(4) Biophysical profile B.P.P.
TIMING OF DELIVERY
 In well controlled diabetic mother ,the
  pregnancy can be continued till 40 wks in the
  absence of any complications .
Indication for induction of labour.
 Uncomplicated diabetes at 40 wks
 Developing macrosemia at 38 wks
 Pre eclampsia
MANAGEMENT DURING
LABOUR
 Vaginal delivery: preferred
 Cesarian section only for routine obstetric
    indication
       GDM alone is not an indication !
   > 4.5 Kg fetus: Cesarean delivery may reduce the
    likelihood of brachial plexus injury in the infant
    and still birth
   Maintain euglycemia during labor 4-7mmol/L
   Monitor sugars 1-4 hrly intervals during labour
   Give insulin only if blood sugar >120 mg/dl
IV INSULIN DURING C-
SECTION
 I.V insulin infusion.
 50 ml N/S +50 unit regular insulin Aim at 1-2
  unit (1ml)/hr.
 At the same time 10% of glucose started on
  other arm.
 BSL b/w 4.0-7.0 mmol/L
POST-PARTUM FOLLOW UP

 Check blood sugars before discharge
 Lifestyle modification: exercise, weight
  reduction
 Oral glucose tolerance test at 6-12 weeks
  postpartum
 Counseling for contra-ception, and pre-
  conception care for next pregnancy
IMMEDIATE MANAGEMENT OF
NEONATE
 Hypoglycemia<40 mg/dl : 50 % of
  macrosomic infants
 Encourage early breast feeding
 If symptomatic give a bolus of 2- 4 ml/kg, IV,
  10% dextros
 Check for calcium, if seizure/irritability/RDS
Conclusion
 Gestational diabetes is a common problem in
  worldwide
 Risk stratification and screening is essential
  in all pregnant women.
 Tight glycemic targets are required for good
  maternal and fetal outcome
 Patient education and Long term follow up is
  essential
17 POUNDS BABY BORN OF A WOMEN
WITH GDM
Gestational diabetes mellitus

More Related Content

What's hot

Gdm ho presentation
Gdm ho presentationGdm ho presentation
Gdm ho presentation
limgengyan
 
Diabetes In Pregnancy
Diabetes In PregnancyDiabetes In Pregnancy
Diabetes In Pregnancy
Marga artes
 
Diabetes mellitus in pregnancy
Diabetes mellitus in pregnancyDiabetes mellitus in pregnancy
Diabetes mellitus in pregnancy
Prativa Dhakal
 

What's hot (20)

Gestational diabetes mellitus (2)
Gestational diabetes mellitus (2)Gestational diabetes mellitus (2)
Gestational diabetes mellitus (2)
 
Diabetes in Pregnancy
Diabetes in PregnancyDiabetes in Pregnancy
Diabetes in Pregnancy
 
Pregestational Diabetes in pregnancy
Pregestational Diabetes in pregnancyPregestational Diabetes in pregnancy
Pregestational Diabetes in pregnancy
 
Gdm ho presentation
Gdm ho presentationGdm ho presentation
Gdm ho presentation
 
Diabetes in pregnancy
Diabetes in pregnancy Diabetes in pregnancy
Diabetes in pregnancy
 
Diabetes in Pregnancy
Diabetes in PregnancyDiabetes in Pregnancy
Diabetes in Pregnancy
 
Gestational Diabetes Mellitus
Gestational Diabetes MellitusGestational Diabetes Mellitus
Gestational Diabetes Mellitus
 
Gestational Diabetes Mellitus (GDM)
Gestational Diabetes Mellitus (GDM)Gestational Diabetes Mellitus (GDM)
Gestational Diabetes Mellitus (GDM)
 
Diabetes In Pregnancy
Diabetes In PregnancyDiabetes In Pregnancy
Diabetes In Pregnancy
 
GESTATIONAL DIABETES MELLITUS
GESTATIONAL DIABETES MELLITUSGESTATIONAL DIABETES MELLITUS
GESTATIONAL DIABETES MELLITUS
 
Dm in pregnancy
Dm in pregnancyDm in pregnancy
Dm in pregnancy
 
Gestational diabetes
Gestational diabetes Gestational diabetes
Gestational diabetes
 
Diabetes & Pregnancy
Diabetes & PregnancyDiabetes & Pregnancy
Diabetes & Pregnancy
 
Diabetes in pregnancy
Diabetes in pregnancyDiabetes in pregnancy
Diabetes in pregnancy
 
diabetes in pregnancy
diabetes in pregnancydiabetes in pregnancy
diabetes in pregnancy
 
GDM
GDMGDM
GDM
 
Diabetes in pregnancy
Diabetes in pregnancyDiabetes in pregnancy
Diabetes in pregnancy
 
Dipsi guidelines
Dipsi guidelinesDipsi guidelines
Dipsi guidelines
 
Diabetes mellitus in pregnancy
Diabetes mellitus in pregnancyDiabetes mellitus in pregnancy
Diabetes mellitus in pregnancy
 
GDM_ Dr Selim
GDM_ Dr SelimGDM_ Dr Selim
GDM_ Dr Selim
 

Similar to Gestational diabetes mellitus

gestationaldiabetesmellitus-190918054714.pdf
gestationaldiabetesmellitus-190918054714.pdfgestationaldiabetesmellitus-190918054714.pdf
gestationaldiabetesmellitus-190918054714.pdf
Derique2
 
Diabetes&pregnancy
Diabetes&pregnancyDiabetes&pregnancy
Diabetes&pregnancy
drmcbansal
 

Similar to Gestational diabetes mellitus (20)

Gestational Diabetes Mellitus.pptx
Gestational Diabetes Mellitus.pptxGestational Diabetes Mellitus.pptx
Gestational Diabetes Mellitus.pptx
 
GDM
GDMGDM
GDM
 
gdm (1).pptx
gdm (1).pptxgdm (1).pptx
gdm (1).pptx
 
Gestational Diabetes Mellitus
Gestational Diabetes MellitusGestational Diabetes Mellitus
Gestational Diabetes Mellitus
 
gdm (1).pptx
gdm (1).pptxgdm (1).pptx
gdm (1).pptx
 
gestationaldiabetesmellitus-190918054714.pdf
gestationaldiabetesmellitus-190918054714.pdfgestationaldiabetesmellitus-190918054714.pdf
gestationaldiabetesmellitus-190918054714.pdf
 
Gestational diabetes
Gestational diabetesGestational diabetes
Gestational diabetes
 
Gestational diabetes mellitus
Gestational diabetes mellitusGestational diabetes mellitus
Gestational diabetes mellitus
 
Diabetes Mellitus in pregnancy " Gestational diabetes mellitus''
Diabetes Mellitus in pregnancy " Gestational diabetes mellitus''Diabetes Mellitus in pregnancy " Gestational diabetes mellitus''
Diabetes Mellitus in pregnancy " Gestational diabetes mellitus''
 
Diabetes in Pregnancy management all.pptx
Diabetes in Pregnancy management all.pptxDiabetes in Pregnancy management all.pptx
Diabetes in Pregnancy management all.pptx
 
Ruba presentation
Ruba presentationRuba presentation
Ruba presentation
 
Diabetes&pregnancy
Diabetes&pregnancyDiabetes&pregnancy
Diabetes&pregnancy
 
Gestational diabetes
Gestational diabetesGestational diabetes
Gestational diabetes
 
Diabetes in Pregnancy.pptx
Diabetes in Pregnancy.pptxDiabetes in Pregnancy.pptx
Diabetes in Pregnancy.pptx
 
Presentation 28.pptx
Presentation 28.pptxPresentation 28.pptx
Presentation 28.pptx
 
Gdm 4
Gdm 4Gdm 4
Gdm 4
 
Gestational Diabetes by Dr Shahjada Selim
Gestational Diabetes by Dr Shahjada SelimGestational Diabetes by Dr Shahjada Selim
Gestational Diabetes by Dr Shahjada Selim
 
RECENT ADVANCES IN THE MANAGEMENT OF GESTATIONAL DIABETES AND PRE-ECLAMPSIA
RECENT ADVANCES IN THE MANAGEMENT OF GESTATIONAL DIABETES AND PRE-ECLAMPSIARECENT ADVANCES IN THE MANAGEMENT OF GESTATIONAL DIABETES AND PRE-ECLAMPSIA
RECENT ADVANCES IN THE MANAGEMENT OF GESTATIONAL DIABETES AND PRE-ECLAMPSIA
 
Gestational dm
Gestational dmGestational dm
Gestational dm
 
All about Gestational Diabetes Mellitus,
All about Gestational Diabetes Mellitus,All about Gestational Diabetes Mellitus,
All about Gestational Diabetes Mellitus,
 

Recently uploaded

Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
MedicoseAcademics
 

Recently uploaded (20)

Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)
 
Factors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryFactors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric Dentistry
 
Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)
 
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
 
Anuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentAnuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatment
 
MALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptx
MALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptxMALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptx
MALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptx
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
Compare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from homeCompare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from home
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
Aptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal TestimonyAptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal Testimony
 
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t..."Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
 
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. MacklinScleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
 
In-service education (Nursing Mangement)
In-service education (Nursing Mangement)In-service education (Nursing Mangement)
In-service education (Nursing Mangement)
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European Union
 
Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptx
 
Gauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxGauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptx
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
 
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
 

Gestational diabetes mellitus

  • 1.
  • 2. Gestational Diabetes (GD) Presented by DR . HINA KHUDA-I-DAD Working under supervision of PROF. DR .TASNEEM ASHRAF HEAD OF DEPARTMENT GYNAE UNIT IV
  • 3. INTRODUCTION Gestational diabetes is Any degree of Glucose intolerance with onset or first recognition during pregnancy. It affects 3-5% of all pregnancies.
  • 4. PRENATAL MANAGEMENT 1- Screening and diagnosis 2-PATIENT’S EDUCATION 3-GLYCEMIC TARGETS 4-DIET AND EXERCISE 5-INSULIN AND ORAL HYPO- GLYCEMIC DRUGS 6-MONITORING FETAL GROWTH
  • 5. WHO SHOULD BE SCREENED AND WHY Risk stratification  Low risk: no screening  Average risk: at 24-28 weeks  High risk: as soon as possible
  • 6. LOW RISK  Age <25 years  Weight normal before pregnancy  Member of an ethnic group with a low  prevalence of GDM  No known diabetes in first-degree relatives  No history of abnormal glucose tolerance  No history of poor obstetric outcome In the presence of all these factors no screening is recommended
  • 7. INTERMEDIATE RISK  Must exhibit one risk factor of GDM.
  • 8. Caution High risk of gestational diabetes  Marked obesity BMI >30.  Previous history of gestational diabetes mellitus.  Strong family history of diabetes .  Native Americans, Asians, Hispanics, African AND arabic specially of mid-eastern origin.  Previous macrosomic babies, unexplained stillbirths. women with risk factors should be screened as soon as possible
  • 9. Oral glucose tolerance test Prerequisites:  Normal diet for 3 days before the test.  At least 10 hours fast ,in morning at rest. Give 100 gm of glucose in 250 ml water Criteria for glucose tolerance test: fasting 5.3 mmol/L 1 hour 10 mmol/L 2 hours 8.6 mmol/L 3 hours 7.8 mmol/L If any 2 or more of these values are elevated, the patient is DIAGNOSED to have GDM.ADA CRITERIA
  • 10. Patient education cornerstone in GDM management  Inform mother about maternal and fetal complications  Diet therapy  Teach mother about self monitored blood glucose measurement and glycemic targets  Fetal monitoring: ultrasound  Planning on delivery
  • 11. Potential Risks of Untreated GDM IN CHILD 1,Growth abnormalities -Macrosomia 2,Chemical imbalance -Hypoglycemia -Jaundice -Hypocalcemia Prone for diabetes in future
  • 12. Potential Risks of Untreated GDM in mother  PIH and Pre-eclampsia: affects 10-25% of all pregnant women with GDM  Infections: high incidence of chorioamnionitis and postpartum endometritis  Postpartum bleeding: caused by exaggerated uterine distension  Ceasarian section due to fetal macrosmia and cephalo- pelvic disproportion  Weight gain  Third trimester fetal deaths  Long term risk of type-2 diabetes mellitus
  • 13. GLYCEMIC TARGET 1.Fasting <5.9mmol/L 2.1 hr post prandial <7.8 mmol/L
  • 14. Self monitored blood glucose (SBMG) 4 times/day minimum, fasting and 1 or 2 hours after meals Maintain log book
  • 15. DIET
  • 16. Diet Proteins not more than 1g/kg Fats < 35% of energy intake Cho <55% of energy intake Salt <6g/day In 3 meals and 3 snacks
  • 17. Exercise  Means regular, moderate physical activity like 1. Walking for 14-30 minutes 2. Prenatal Aerobic classes 3. Swimming
  • 18. INSULIN THERAPY  If persistent hyperglycemia after one week of diet control proceed to insulin
  • 19. INSULIN IN GDM  Insulin used if fasting blood glucose >105 mg/dl or 2 hr postprandial blood glucose >120 mg / dl on a diet  Use intermittent bolus regime of Short acting insulins to cover each meal.  Insulin requirements increase by 50% from 20-24 weeks to 30-32 weeks, after which insulin needs often stabilize.
  • 20.
  • 21. ORAL HYPOGLYCEMIC AGENTS  Glyburide is a clinically effective alternative to insulin in GDM (Langer et al. 2000)  Metformin may be effective in GDM (Ratner et al., 2008; Coustan, 2007
  • 22. HYPOGLYCEMIA  During treatment with insulin patient can have low blood sugar <60mg/dl  Why does low blood sugar occur? 1. Too much exercise 2. Skipping meals or snacks 3. Delaying meals or snacks 4. Not eating enough 5. Too much insulin
  • 23. SYMPTOMS OF HYPOGLYCEMIA  Very hungry  Very tired  Shaky or trembling  Sweating or clamminess  Nervous  Confused  Like going to pass out or faint  Blurred vision
  • 24. Hypoglycemia Prevention Strategies Consistent monitoring
  • 25. Fetal monitoring (1) Ultrasound :NICE guideline is to assess fetal growth on 4 weekly basis from 28-36wks  Fetal growth ,Amniotic fluid volume at 28,32,36 wks polyhydramnios (2) cardiotocography (C.T.G). after 32 wks (3) Doppler. (4) Biophysical profile B.P.P.
  • 26. TIMING OF DELIVERY  In well controlled diabetic mother ,the pregnancy can be continued till 40 wks in the absence of any complications . Indication for induction of labour.  Uncomplicated diabetes at 40 wks  Developing macrosemia at 38 wks  Pre eclampsia
  • 27. MANAGEMENT DURING LABOUR  Vaginal delivery: preferred  Cesarian section only for routine obstetric indication  GDM alone is not an indication !  > 4.5 Kg fetus: Cesarean delivery may reduce the likelihood of brachial plexus injury in the infant and still birth  Maintain euglycemia during labor 4-7mmol/L  Monitor sugars 1-4 hrly intervals during labour  Give insulin only if blood sugar >120 mg/dl
  • 28. IV INSULIN DURING C- SECTION  I.V insulin infusion.  50 ml N/S +50 unit regular insulin Aim at 1-2 unit (1ml)/hr.  At the same time 10% of glucose started on other arm.  BSL b/w 4.0-7.0 mmol/L
  • 29. POST-PARTUM FOLLOW UP  Check blood sugars before discharge  Lifestyle modification: exercise, weight reduction  Oral glucose tolerance test at 6-12 weeks postpartum  Counseling for contra-ception, and pre- conception care for next pregnancy
  • 30. IMMEDIATE MANAGEMENT OF NEONATE  Hypoglycemia<40 mg/dl : 50 % of macrosomic infants  Encourage early breast feeding  If symptomatic give a bolus of 2- 4 ml/kg, IV, 10% dextros  Check for calcium, if seizure/irritability/RDS
  • 31. Conclusion  Gestational diabetes is a common problem in worldwide  Risk stratification and screening is essential in all pregnant women.  Tight glycemic targets are required for good maternal and fetal outcome  Patient education and Long term follow up is essential
  • 32. 17 POUNDS BABY BORN OF A WOMEN WITH GDM